An item in the May 19, 2011, edition of BioWorld Today's Appointments and Advancements column should have said that Adimab LLC appointed Frances Heller to its board

Addex Pharmaceuticals Ltd., of Geneva, added Hoyoung Huh and Oleg Nodelman to its board...Aileron Therapeutics Inc., of Cambridge, Mass., named Julian Adams, Scott Kapnick and John H. McArthur to its board, and named Stephen W. Fesik, Robert H. Grubbs and Michael Hanley to its scientific advisory board

Concert Pharmaceuticals Inc., of Lexington, Mass., appointed Mark Roessel vice president of regulatory affairs and quality assurance and named LuAnn Sabounjian vice president of clinical operations...Infinity Pharmaceuticals Inc., of Cambridge, Mass., appointed Joshua D. Hamermesh vice president of business and corporate development...Lightlake Therapeutics Inc., of London, appointed Cynthia McCormick as senior clinical and regulatory advisor

Hospira Inc., of Lake Forest, Ill., elected F. Michael (Mike) Ball CEO and board member...ITherX Pharmaceuticals Inc., of San Diego, named Stefan Zeuzem chairman of its scientific and clinical advisory board

Addex Pharmaceuticals Ltd., of Geneva, proposed adding Hoyoung Huh and Oleg Nodelman to the board...Codexis Inc., of Redwood City, Calif., named Jacques Beaudry-Losique vice president of corporate development and strategy

Pearl Therapeutics Inc., of Redwood City, Calif., appointed Chuck Bramlage president and CEO...Plethora Solutions Holdings plc, of London, appointed Richard Horsman to its board and named Billy Hargan vice president of commercial operations...Protox Therapeutics Inc., of Vancouver, British Columbia, named William Rohn and Arnit Sobti to its board

ATyr Pharma, of San Diego, formed a therapeutic advisory board comprising Thomas O. Daniel, L. Patrick Gage, Rich Heyman, Keith James, Paul Negulescu, Timothy Rink, Wendell Wierenga and Doug Williams...Otonomy Inc., of San Diego, appointed G. Michael Wall vice president of product development and named Cindy Berejikian vice president of program management

executive vice president and chief operating officer and named John A. Bellano senior vice president of sales and commercial programs

The firm also named Lori M. Henderson vice president, general counsel and secretary...Anadys Pharmaceuticals Inc., of San Diego, named Kevin L. Eastwood senior vice president of corporate development, promoted James Appleman to senior vice president of research and chief scientific officer, appointed James L. Freddo to the board and named Stelios Papadopoulos chairman...AspenBio Pharma Inc., of Castle Rock, Colo., added Erik S. Miller as vice president of marketing and business development

Markus Leyck Dieken senior vice president and general manager, Germany...and Manuela Maronati vice president, sales and marketing, Europe

Receptos Inc., of San Diego, appointed Faheem Hasnain president, CEO and board member...Selvita, of Krakow Poland, appointed Piotr Prelich vice president of sales and marketing...Topaz Pharmaceuticals Inc., of Horsham, Pa., appointed Bob Radie president and CEO

OctoPlus NV, of Leiden, the Netherlands, named Jan Hendrik Egberts and nominated him for appointment as CEO...Optimer Pharmaceuticals Inc., of San Diego, named Kurt Hartman general counsel and access...Protox Therapeutics Inc., of Vancouver, British Columbia, named Lars Ekman chairman and added Jonathan Leff and Nishan de Silva to the board

and added Tamara A. Seymour as chief financial officer...Hybrigenics, of Paris, named William Vickery head of corporate and business development...Medistem Inc., of San Diego, appointed Vladimir Bogin president and chairman

plc, of Dublin, Ireland, appointed Kristine Peterson to its board and named Joseph S. Zakrzewski CEO...Ambit Biosciences Corp., of San Diego, named Faheem Hasnain chairman and appointed Alan Fuhrman chief financial officer...AnaptysBio Inc., of San Diego, named Jan de Vries, Nicholas B. Lydon and Phillip A. Patten to its scientific and therapeutic advisory boards

Roche, of Nutley, N.J., named Jacques Banchereau senior vice president and head of the inflammation and virology discovery and translational areas

Accera Inc., of Broomfield, Colo., appointed Thomas Werner president and CEO...Agile Therapeutics Inc., of Princeton, N.J., named Al Altomari president and CEO...AIKO Biotechnology, of Portland, Maine, appointed Jim New CEO and added Paul Goldenheim to its board

HemoShear LLC, of Charlottesville, Va., added Robert Ruffolo and Kenneth Batchelor to its scientific advisory board...Horizon Discovery Ltd., of Cambridge, UK, appointed Nigel Pitchford and David Evans to its board...NeoStem Inc., of New York, appointed Ian Zhang president and managing director of NeoStem (China) Inc

BioMarin Pharmaceutical Inc., of Novato, Calif., appointed William D. Young and Kenneth M. Bate to its board...Celgene Corp., of Summit, N.J., appointed Jacqualyn A. Fouse senior vice president and chief financial officer...Cubist Pharmaceuticals Inc., of Lexington, Mass., promoted Steven C. Gilman to executive vice president of R&D and chief scientific officer

Aegerion Pharmaceuticals Inc., of Bridgewater, N.J., named Marc Beer CEO and board member...Aquinox Pharmaceuticals Inc., of Vancouver, British Columbia, appointed Csaba Szabo vice president of research and chief scientific officer...AVEO Pharmaceuticals Inc., of Cambridge, Mass., appointed Michael P. Bailey chief commercial officer and Donna M. Radzik vice president of technical operations